Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$16,575,275
+$1,350,541 QoQ
Shares Held
65,869
-5.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#694
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2025CallValue
$91,396
CallShares
400
PutValue
$91,396
PutShares
400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Freestone Capital Holdings, LLC holds $84,369,882 across 11 Drug Manufacturers - General names. ABBV ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,406 | $32,871,581 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
65,869 | $16,575,275 | |
| 3 | JNJ |
Johnson & Johnson
|
57,366 | $14,569,243 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,532 | $10,219,862 | |
| 5 | AMGN |
Amgen Inc
|
11,780 | $4,265,773 | |
| 6 | NVO |
Novo Nordisk A S
|
37,304 | $1,788,353 | |
| 7 | PFE |
Pfizer Inc
|
55,761 | $1,342,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,873 | $1,121,014 |
All Filings in ABBV
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,575,275 | 65,869 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $15,224,734 | 70,002 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $91,396 | 400 | Put | Defined | 2026-01-23 | |
| 2025-12-31 | $15,814,706 | 69,214 | Shares | Defined | 2026-01-23 | |
| 2025-12-31 | $91,396 | 400 | Call | Defined | 2026-01-23 | |
| 2025-09-30 | $16,082,305 | 69,458 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $12,537,331 | 67,543 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $14,302,463 | 68,263 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,674,179 | 65,696 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $12,660,837 | 64,112 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,366,973 | 66,272 | Shares | Defined | 2024-11-22 | |
| 2024-03-31 | $12,301,037 | 67,551 | Shares | Defined | 2024-11-22 | |
| 2023-12-31 | $9,839,355 | 63,492 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,408,965 | 63,122 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,155,072 | 60,529 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $9,718,223 | 60,979 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,860,472 | 61,014 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,496,565 | 70,759 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $12,044,961 | 78,643 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $14,786,701 | 91,214 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $13,002,462 | 96,030 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,956,940 | 92,305 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,253,150 | 82,148 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,777,399 | 81,107 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,934,488 | 83,383 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $6,354,391 | 72,547 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $7,031,455 | 71,618 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $4,147,707 | 54,439 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||